"Healthgrades®, the leading online resource for comprehensive information about physicians and hospitals, has honored Washington Hospital Healthcare System with a 2018 America’s 100 Best Hospitals™ award. And, that’s not all. Healthgrades has also named us one of America’s 100 Best Hospitals for Orthopedic Surgery™. For the Best Hospitals survey, Healthgrades evaluated nearly 4,500 hospitals nationwide for the most common inpatient procedures and conditions, and reviewed outcome data. The Best Hospital distinction places Washington Hospital Healthcare System among the top 2% of hospitals in the U.S."

During the past decade, Washington Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 16 clinical trials were completed, i.e. on average, 106.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 8 clinical trials were completed. i.e. 88.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Washington Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 11 trials, followed by "SWOG Cancer Research Network" with 6 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "Abbott Medical Devices" with 3 trials sponsored and "Radiation Therapy Oncology Group" with 3 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Washington Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 18 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "North Central Cancer Treatment Group" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Washington Hospital" are "Breast Cancer" (5 trials), "Breast Adenocarcinoma" (3 trials), "Invasive Breast Carcinoma" (3 trials), "Breast Ductal Carcinoma In Situ" (2 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "Washington Hospital" in a lesser frequency.

Most popular intervention types in "Washington Hospital" are "Drug" (27 trials), "Other" (18 trials), "Biological" (11 trials), "Radiation" (9 trials) and "Device" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (10 trials), "Quality-of-Life Assessment" (8 trials), "Paclitaxel" (6 trials), "Docetaxel" (5 trials) and "Radiation Therapy" (5 trials). Other intervention names were less common.

The vast majority of trials in "Washington Hospital" are 24 trials for "All" genders, 9 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Washington Hospital". undefined are not yet recruiting, 8 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Washington Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Washington Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".